CD40LG and long COVID-19: Limitations of this study include the (i) use of deidentified samples so a correlation with PASC symptoms could not be determined, (ii) a relatively small sample size, and (iii) the inability of our assay to distinguish between IgG and IgM ACE2 antibodies.